OXALIPLATIN INJECTION
Google image searchProduct monograph
Active ingredient
oxaliplatin, 5 MG/ML
DIN: 02435071
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE USE VIAL
Schedule: Prescription
Company: TEVA CANADA LIMITED
Date: 16-DEC-2015
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
- L01XA — Platinum compounds (ATC, ATC/DDD)
- L01XA03 — OXALIPLATIN (ATC/DDD)
Reference brand drug: Eloxatin
Pharmaceutical standard: MFR
External Links for Oxaliplatin Injection
Search on Google
- Oxaliplatin Injection side effects
- Oxaliplatin Injection dosage
- oxaliplatin side effects
- oxaliplatin dosage
Teva Canada Limited
Go to Teva website to see drug product details. Sometimes you can find oxaliplatin injection photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.